Roth Capital Keeps Lion Bio (LBIO) at 'Buy' Following Juno's (JUNO) ROCKET Study Update Nov 23, 2016 11:28AM
Roth Sees Lion Biotech's (LBIO) NCI Announcement as Important Given Impact on Thesis; Affirms at 'Buy' Aug 25, 2016 08:45AM
Lion Biotechnologies (LBIO): Unfairly Caught in Juno Concerns - Roth Jul 8, 2016 08:58AM
Lion Biotech's (LBIO) Collaboration with MedImmune (AZN) Indicates Increasing TIL Interest - Roth Capital Dec 21, 2015 10:30AM
Roth Capital Affirms Lion Bio (LBIO) at 'Buy' Following Positive TIL Phase 2 Data in Metastatic Melanoma Sep 17, 2015 07:23AM


Aug 25, 2015 09:28AM Roth Capital Highlights Biotech Picks 'for the Turn' and Over the Long Haul (PTN) (LGND) (TGTX) (CLDX)
Jun 30, 2015 08:09AM Celgene/Juno Deal Bodes Well For Lion Biotechnologies (LBIO), Roth Capital Says
Apr 1, 2015 12:29PM Multiple Positives Appear from Latest Publication of Lion Biotech's (LBIO) TIL Data - Roth
Mar 30, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 3/30: (MGA) (YELP) (AAPL) (BBRY)
Mar 30, 2015 11:55AM Lion Biotechnologies (LBIO) Receives First External Validation of Phase I TIL/Yervoy in Metastatic Melanoma; Roth Capital Affirms at 'Buy'
Feb 26, 2015 09:33AM Pre-Open Stock Movers 02/26: (ELX) (CYBX) (UIL) (CRM) Higher; (CLRX) (LKQ) (TASR) Lower (more...)
Feb 26, 2015 08:24AM Lion Biotechnologies (LBIO) Prices 8M Common Offering at $8/Share